ImmunityBio, Inc. (IBRX)
USD 2.84
(-4.38%)
USD 2.84
(-4.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 618.22 Million USD | -0.15% |
| 2022 | 619.13 Million USD | 33.27% |
| 2021 | 464.56 Million USD | 93.06% |
| 2020 | 240.63 Million USD | 36559.39% |
| 2019 | -660 Thousand USD | 93.34% |
| 2018 | -9.91 Million USD | 40.31% |
| 2017 | -16.6 Million USD | -13174.02% |
| 2016 | 127 Thousand USD | 100.07% |
| 2015 | -173.44 Million USD | -194.77% |
| 2014 | -58.83 Million USD | -4272.98% |
| 2013 | 1.41 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 762.38 Million USD | 23.32% |
| 2024 Q2 | 868.85 Million USD | 13.96% |
| 2023 Q3 | 539.3 Million USD | -30.47% |
| 2023 FY | 618.22 Million USD | -0.15% |
| 2023 Q1 | 677.77 Million USD | 9.47% |
| 2023 Q2 | 775.65 Million USD | 14.44% |
| 2023 Q4 | 618.22 Million USD | 14.63% |
| 2022 Q2 | 602.77 Million USD | -1.57% |
| 2022 Q4 | 619.13 Million USD | 1.86% |
| 2022 Q3 | 607.81 Million USD | 0.84% |
| 2022 FY | 619.13 Million USD | 33.27% |
| 2022 Q1 | 612.41 Million USD | 31.83% |
| 2021 Q4 | 464.56 Million USD | 68.06% |
| 2021 FY | 464.56 Million USD | 93.06% |
| 2021 Q2 | 247.84 Million USD | -9.65% |
| 2021 Q3 | 276.43 Million USD | 11.54% |
| 2021 Q1 | 274.31 Million USD | 14.0% |
| 2020 Q2 | -90.14 Million USD | -2684.77% |
| 2020 FY | 240.63 Million USD | 36559.39% |
| 2020 Q4 | 240.63 Million USD | 19.32% |
| 2020 Q3 | 201.66 Million USD | 323.72% |
| 2020 Q1 | -3.23 Million USD | -102.67% |
| 2019 Q4 | 121.32 Million USD | 5298.29% |
| 2019 Q3 | -2.33 Million USD | -2.28% |
| 2019 Q2 | -2.28 Million USD | 64.91% |
| 2019 Q1 | -6.5 Million USD | 34.38% |
| 2019 FY | -660 Thousand USD | 93.34% |
| 2018 FY | -9.91 Million USD | 40.31% |
| 2018 Q1 | -4.17 Million USD | 74.87% |
| 2018 Q3 | -8 Million USD | 13.62% |
| 2018 Q4 | -9.91 Million USD | -23.78% |
| 2018 Q2 | -9.27 Million USD | -122.14% |
| 2017 Q3 | -13.41 Million USD | 19.57% |
| 2017 Q1 | -5.61 Million USD | -4521.26% |
| 2017 Q2 | -16.67 Million USD | -196.99% |
| 2017 Q4 | -16.6 Million USD | -23.79% |
| 2017 FY | -16.6 Million USD | -13174.02% |
| 2016 Q4 | 127 Thousand USD | 100.54% |
| 2016 Q2 | -35.8 Million USD | 41.11% |
| 2016 Q3 | -23.7 Million USD | 33.81% |
| 2016 FY | 127 Thousand USD | 100.07% |
| 2016 Q1 | -60.79 Million USD | 64.95% |
| 2015 FY | -173.44 Million USD | -194.77% |
| 2015 Q1 | -49.85 Million USD | 15.27% |
| 2015 Q4 | -173.44 Million USD | 51.64% |
| 2015 Q2 | -120.43 Million USD | -141.58% |
| 2015 Q3 | -358.61 Million USD | -197.76% |
| 2014 FY | -58.83 Million USD | -4272.98% |
| 2014 Q4 | -58.83 Million USD | 0.0% |
| 2013 FY | 1.41 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 1205.156% |
| Alkermes plc | -166.73 Million USD | 470.773% |
| Agenus Inc. | 274.13 Million USD | -125.517% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 66.939% |
| Aptorum Group Limited | 1.35 Million USD | -45456.599% |
| Ardelyx, Inc. | 34.51 Million USD | -1691.331% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -14344.486% |
| Bicycle Therapeutics plc | -481.46 Million USD | 228.404% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -1609.548% |
| ChromaDex Corporation | -24.04 Million USD | 2670.792% |
| Chimerix, Inc. | -25.51 Million USD | 2522.793% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -8772.234% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 2711.074% |
| CRISPR Therapeutics AG | -150.84 Million USD | 509.841% |
| Precision BioSciences, Inc. | -85.41 Million USD | 823.831% |
| Dyadic International, Inc. | -6.37 Million USD | 9792.919% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 3980.148% |
| Fortress Biotech, Inc. | 7.66 Million USD | -7965.545% |
| Lantern Pharma Inc. | -21.7 Million USD | 2948.528% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 659.291% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 7336.466% |
| Incyte Corporation | -3.17 Billion USD | 119.471% |
| IO Biotech, Inc. | -140.69 Million USD | 539.395% |
| Jaguar Health, Inc. | 29.39 Million USD | -2003.447% |
| Novavax, Inc. | -298.29 Million USD | 307.253% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -11483.736% |
| Opthea Limited | 28.15 Million USD | -2095.597% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 3782.316% |
| ContextLogic Inc. | -232 Million USD | 366.476% |
| MiMedx Group, Inc. | -33.9 Million USD | 1923.616% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -5963.992% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 26781.778% |
| NextCure, Inc. | -6.47 Million USD | 9644.913% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 1324.182% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 9791.55% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -4982.713% |
| Vaxcyte, Inc. | -368.22 Million USD | 267.892% |
| PDS Biotechnology Corporation | -32.7 Million USD | 1990.079% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -3478.099% |
| Pharming Group N.V. | 109.8 Million USD | -463.025% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 3653.828% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 452.807% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3438.169% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3438.169% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 8807.38% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 10649.898% |
| Acelyrin, Inc. | -216.9 Million USD | 385.023% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 11119.511% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 35959.861% |
| Summit Therapeutics Inc. | 34.67 Million USD | -1682.961% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 9187.52% |
| Senti Biosciences, Inc. | 1.74 Million USD | -35430.115% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 434.887% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 898.213% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 10298.35% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -619555.405% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -98343.312% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 628.189% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 467.481% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -457.612% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 8238.81% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 578.82% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -8866.788% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 355.082% |
| Immix Biopharma, Inc. | -17.5 Million USD | 3630.733% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 295.206% |
| MEI Pharma, Inc. | -3.7 Million USD | 16786.208% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -4841.444% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -282.228% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -2124.387% |
| Fortress Biotech, Inc. | 7.66 Million USD | -7965.545% |
| Precigen, Inc. | -481 Thousand USD | 128628.898% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -4290.484% |
| AlloVir, Inc. | -62.69 Million USD | 1086.129% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 1211.634% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -902.536% |
| ImmuCell Corporation | 10.99 Million USD | -5525.044% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 501.064% |
| Onconetix, Inc. | 5.33 Million USD | -11495.823% |
| PureTech Health plc | -167.19 Million USD | 469.758% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 2129.626% |
| Elevation Oncology, Inc. | -19.11 Million USD | 3333.727% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 12693.685% |
| Seer, Inc. | -4.24 Million USD | 14680.755% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 2671.968% |
| Innoviva, Inc. | 255.56 Million USD | -141.907% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 1206.659% |
| ESSA Pharma Inc. | -33.62 Million USD | 1938.771% |
| GlycoMimetics, Inc. | -40.98 Million USD | 1608.436% |
| GT Biopharma, Inc. | -1.02 Million USD | 60650.833% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 1012.063% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -909.23% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 561.089% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 4561.778% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 2241.258% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 820744.066% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 2103.188% |
| Aptose Biosciences Inc. | -8.19 Million USD | 7644.049% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 19857.764% |
| Soligenix, Inc. | -4.95 Million USD | 12585.346% |
| Century Therapeutics, Inc. | 847 Thousand USD | -72889.847% |
| Kura Oncology, Inc. | -20.11 Million USD | 3172.989% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 1610.59% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 7461.562% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -33836.746% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 19437.629% |
| Autolus Therapeutics plc | -186.59 Million USD | 431.312% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 1353.902% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 324.162% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -1704.085% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -276.122% |
| GRI Bio, Inc. | -1.79 Million USD | 34560.647% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 6982.12% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 1958.929% |
| IGM Biosciences, Inc. | -72.6 Million USD | 951.478% |
| INmune Bio, Inc. | -25.41 Million USD | 2532.899% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -309.553% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1320.363% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 3904.602% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 21529.458% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -1526.263% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 1601.09% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -1838.918% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -63.573% |
| Verastem, Inc. | -37.27 Million USD | 1758.415% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 6913.887% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 1292.056% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 4184.731% |
| Histogen Inc. | -7.48 Million USD | 8357.299% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 2961.245% |
| Surrozen, Inc. | -32.66 Million USD | 1992.677% |
| Organovo Holdings, Inc. | -1.5 Million USD | 41123.49% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 14807.405% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -3160.639% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -23532.416% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -14775.457% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 7476.362% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 1523.102% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 4341.133% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 295.153% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 85719.478% |
| Apollomics, Inc. | -27.39 Million USD | 2356.704% |
| Amarin Corporation plc | -191.04 Million USD | 423.61% |
| Mesoblast Limited | 55.96 Million USD | -1004.701% |
| Turnstone Biologics Corp. | -14.58 Million USD | 4339.057% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 2544.346% |
| Synaptogenix, Inc. | -28.66 Million USD | 2256.984% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 66149.573% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -1168.62% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 71812.318% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 8608.357% |
| Exelixis, Inc. | -73.05 Million USD | 946.303% |
| Better Therapeutics, Inc. | -860 Thousand USD | 71986.512% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 2674.539% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 356.13% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -83890.294% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 8411.546% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -49200.16% |
| Gritstone bio, Inc. | 39.49 Million USD | -1465.52% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 835.097% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 23587.505% |
| Avid Bioservices, Inc. | 169.72 Million USD | -264.244% |
| Insmed Incorporated | 721.62 Million USD | 14.328% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 6862.82% |
| MediWound Ltd. | -5.32 Million USD | 11716.385% |
| OmniAb, Inc. | 9.2 Million USD | -6617.636% |
| Alector, Inc. | -35.63 Million USD | 1834.781% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -619.108% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 12645.13% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -4569.718% |
| Zai Lab Limited | -775 Million USD | 179.771% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -81.534% |
| Aura Biosciences, Inc. | -21.52 Million USD | 2972.121% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 849.544% |
| Immunic, Inc. | -45.34 Million USD | 1463.529% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 419.967% |
| Veracyte, Inc. | -203.82 Million USD | 403.313% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 3.144% |
| FibroGen, Inc. | 56.76 Million USD | -989.055% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -6842.437% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 21967.919% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 29960.874% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 86.532% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 18604.16% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 472.505% |
| TG Therapeutics, Inc. | 17.86 Million USD | -3361.113% |
| Galecto, Inc. | -21.21 Million USD | 3013.952% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 2699.218% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 60.608% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 2626.25% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 5472.591% |
| XBiotech Inc. | -200.02 Million USD | 409.076% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 835.097% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -13553.357% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 1853.18% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 900.622% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -10763.188% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 462.776% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 769.262% |
| Vaxxinity, Inc. | 10.13 Million USD | -6001.698% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 16.033% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 5841.547% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 1037.328% |
| NexImmune, Inc. | -3.13 Million USD | 19828.603% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 18005.663% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 4191.096% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 2381.269% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 6987.482% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 496366.507% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 1623.77% |
| Ainos, Inc. | 4.07 Million USD | -15060.248% |
| Pluri Inc. | 22.82 Million USD | -2608.064% |
| Prothena Corporation plc | -608.34 Million USD | 201.624% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 620.583% |
| Celularity Inc. | 65.19 Million USD | -848.342% |
| Rallybio Corporation | -24.1 Million USD | 2665.032% |
| Cue Biopharma, Inc. | -33.81 Million USD | 1928.037% |
| MeiraGTx Holdings plc | -40.3 Million USD | 1633.978% |
| Omeros Corporation | 331.17 Million USD | -86.675% |
| Humacyte, Inc. | -22.48 Million USD | 2849.373% |
| Immunocore Holdings plc | -358.59 Million USD | 272.402% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 2615.662% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 2100.66% |
| Blueprint Medicines Corporation | 702.83 Million USD | 12.039% |
| CalciMedica, Inc. | -5.53 Million USD | 11279.458% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 428.458% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 6152.712% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 1644.132% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 1959.153% |
| Pulmatrix, Inc. | -10.41 Million USD | 6034.76% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 10443.383% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 1720.848% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 654.949% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 1131.336% |
| Cytokinetics, Incorporated | 642.37 Million USD | 3.759% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 10716.933% |
| Nutriband Inc. | -251.65 Thousand USD | 245761.357% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 1911.964% |
| Vor Biopharma Inc. | 4.3 Million USD | -14277.302% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 110.242% |
| Evogene Ltd. | -19.63 Million USD | 3248.742% |
| ProKidney Corp. | -56.23 Million USD | 1199.339% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 1370.184% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 6792.773% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 54.672% |
| CorMedix Inc. | -43.05 Million USD | 1535.977% |
| BioLineRx Ltd. | 7.33 Million USD | -8327.263% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 2350.952% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -1239.684% |
| Atai Life Sciences N.V. | -28.55 Million USD | 2264.801% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -27616.474% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 2809.607% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -3385.898% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 923.486% |
| MediciNova, Inc. | -50.78 Million USD | 1317.371% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 884.498% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 2748372.954% |
| GeoVax Labs, Inc. | -6.45 Million USD | 9681.022% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 409.389% |
| Biomea Fusion, Inc. | -166.57 Million USD | 471.15% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 445.425% |
| Mereo BioPharma Group plc | -51.46 Million USD | 1301.158% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 751.832% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 310.453% |
| Absci Corporation | -72.59 Million USD | 951.572% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -13439.728% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 363.706% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 756.212% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 746.029% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 1682.228% |
| Allakos Inc. | -24.97 Million USD | 2575.371% |
| Imunon, Inc. | -4.21 Million USD | 14771.232% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 4293.624% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 556.591% |
| BioAtla, Inc. | -109.01 Million USD | 667.121% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -83890.294% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 65938.552% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -5066.505% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 3015.738% |
| XOMA Corporation | -29 Million USD | 2231.807% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 3833.237% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 6956.965% |
| aTyr Pharma, Inc. | -7.44 Million USD | 8399.423% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 596.024% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 396.989% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 855.969% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 766.455% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 72054.785% |
| Akari Therapeutics, Plc | -3.84 Million USD | 16178.648% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -37994.018% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 55.23% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 52133.144% |
| UroGen Pharma Ltd. | 4.39 Million USD | -13979.344% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -444.782% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -858997.859% |
| Orgenesis Inc. | 21.78 Million USD | -2737.973% |
| Entera Bio Ltd. | -10.62 Million USD | 5916.389% |
| GH Research PLC | -78.07 Million USD | 891.813% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 2873.798% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 2419.007% |
| Xencor, Inc. | 29.64 Million USD | -1985.495% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 31484.924% |
| Replimune Group, Inc. | 1.41 Million USD | -43683.569% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 252531.117% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 589.035% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 52133.144% |
| Portage Biotech Inc. | -4.98 Million USD | 12511.644% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 2748372.954% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 1034.975% |
| OncoCyte Corporation | -6.56 Million USD | 9519.839% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -68789.575% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 13670.51% |
| Purple Biotech Ltd. | -14.13 Million USD | 4472.783% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 2702.391% |
| scPharmaceuticals Inc. | -6.54 Million USD | 9545.745% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 3803.678% |
| HilleVax, Inc. | -165.48 Million USD | 473.583% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 24458.708% |
| Tharimmune, Inc. | -10.93 Million USD | 5753.444% |
| Genprex, Inc. | -6.73 Million USD | 9275.691% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 267.628% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 798.874% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 44227.338% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 18738.35% |
| OKYO Pharma Limited | -826.84 Thousand USD | 74868.761% |
| Savara Inc. | 153 Thousand USD | -403967.975% |
| Curis, Inc. | -23.88 Million USD | 2688.119% |
| Daré Bioscience, Inc. | -5.15 Million USD | 12085.938% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 79766.809% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 10058.505% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -52070.802% |
| BeiGene, Ltd. | -2.25 Billion USD | 127.439% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -4910.528% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 201.647% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 433.12% |
| Erasca, Inc. | -37.21 Million USD | 1761.178% |
| bluebird bio, Inc. | 108.57 Million USD | -469.419% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 48102.746% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -63.228% |
| DBV Technologies S.A. | -126.98 Million USD | 586.844% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 48102.746% |
| Moderna, Inc. | -2.9 Billion USD | 121.267% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 6072.025% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 5788.48% |
| Molecular Templates, Inc. | 707 Thousand USD | -87343.282% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 2070.686% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -78.364% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 853.362% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 773.961% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 2015.667% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 1898.418% |
| MacroGenics, Inc. | -66.98 Million USD | 1022.929% |
| RenovoRx, Inc. | -1.17 Million USD | 52804.518% |
| Adicet Bio, Inc. | -138.78 Million USD | 545.448% |
| Prime Medicine, Inc. | -27.94 Million USD | 2312.605% |
| Aditxt, Inc. | 18.12 Million USD | -3311.666% |
| Adagene Inc. | -87.62 Million USD | 805.515% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 14941.788% |
| Quantum-Si incorporated | -118.55 Million USD | 621.457% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -1617.05% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 8371.454% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 1374.452% |
| SciSparc Ltd. | -2.06 Million USD | 30038.208% |
| Vericel Corporation | 1.27 Million USD | -48312.216% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 5255.432% |
| Minerva Neurosciences, Inc. | 41 Million USD | -1407.707% |
| Generation Bio Co. | 31.44 Million USD | -1865.861% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 452.538% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 2099.237% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -430.241% |
| Invivyd, Inc. | -198.47 Million USD | 411.486% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 784.861% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 25884.169% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 973.321% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 9158.227% |
| 2seventy bio, Inc. | 181.71 Million USD | -240.216% |
| ADMA Biologics, Inc. | 90.06 Million USD | -586.412% |
| Clene Inc. | 3.34 Million USD | -18409.701% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 6906.608% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 2973.99% |
| GeoVax Labs, Inc. | -6.45 Million USD | 9681.022% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 279.652% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 2477.814% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -247.97% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 15209.712% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -12259.536% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 11968.382% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 574.447% |
| Evaxion Biotech A/S | 5.28 Million USD | -11593.63% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 649.2% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 570.945% |
| Trevena, Inc. | 2.25 Million USD | -27279.274% |
| Surrozen, Inc. | -32.66 Million USD | 1992.677% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 1300.202% |
| Cingulate Inc. | 3.08 Million USD | -19954.738% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 21149.506% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -8501.976% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 6753.847% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 879.375% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 570.304% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 685.761% |
| Clearmind Medicine Inc. | -3.94 Million USD | 15780.47% |
| Kronos Bio, Inc. | -36.05 Million USD | 1814.717% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -6470.56% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -42298.502% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 1239.457% |
| Statera Biopharma, Inc. | 14.41 Million USD | -4188.337% |
| Korro Bio, Inc. | -132.94 Million USD | 565.029% |
| Kineta, Inc. | -4.54 Million USD | 13714.27% |
| BioVie Inc. | -17.73 Million USD | 3586.419% |
| Codexis, Inc. | -43.27 Million USD | 1528.726% |
| Celularity Inc. | 65.19 Million USD | -848.342% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 19608.489% |
| Celcuity Inc. | 6.78 Million USD | -9013.631% |
| Virax Biolabs Group Limited | -3.36 Million USD | 18472.49% |
| Cibus, Inc. | -8.07 Million USD | 7753.181% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 14718.681% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -13427.877% |
| IN8bio, Inc. | -16.38 Million USD | 3872.189% |
| Kodiak Sciences Inc. | -103.87 Million USD | 695.161% |
| Annexon, Inc. | -193.75 Million USD | 419.075% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -1717188.892% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 3632.91% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 17698.178% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 41.36% |
| Eyenovia, Inc. | 1.25 Million USD | -49015.994% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -2197.803% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 19163.336% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 1959.488% |
| Arcellx, Inc. | -296.95 Million USD | 308.186% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 3269.404% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 1150.062% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 3082.699% |
| Moolec Science SA | 117.61 Thousand USD | -525529.167% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 1710.0% |
| Geron Corporation | 14.76 Million USD | -4088.226% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 1730.424% |
| Royalty Pharma plc | 5.65 Billion USD | 89.074% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 537.151% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 8945.135% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 11627.881% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 539.295% |
| Humacyte, Inc. | -22.48 Million USD | 2849.373% |
| Structure Therapeutics Inc. | -124.33 Million USD | 597.208% |
| 89bio, Inc. | -289.05 Million USD | 313.879% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 2549.188% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 34773.247% |
| Genelux Corporation | -6.89 Million USD | 9061.067% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 2090.483% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -639.511% |
| Notable Labs, Ltd. | -9.77 Million USD | 6423.895% |
| Liquidia Corporation | -80.17 Million USD | 871.084% |
| Mustang Bio, Inc. | -3.73 Million USD | 16647.752% |
| Immunovant, Inc. | -635.22 Million USD | 197.323% |
| Quantum-Si incorporated | -118.55 Million USD | 621.457% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 3619.836% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 15022.134% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -7601.806% |
| Acasti Pharma Inc. | -23 Million USD | 2787.346% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 18460.022% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 3904.602% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 548.834% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 19938.003% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 2880.784% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 3429.334% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 465.212% |
| PepGen Inc. | -60.67 Million USD | 1118.995% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 2790.738% |
| United Therapeutics Corporation | -507.7 Million USD | 221.77% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 3332.375% |
| Solid Biosciences Inc. | -47.75 Million USD | 1394.71% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 71812.318% |
| Immuneering Corporation | -54.94 Million USD | 1225.213% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 14807.405% |
| Silo Pharma, Inc. | -3.52 Million USD | 17641.713% |
| Belite Bio, Inc | -87.27 Million USD | 808.396% |
| XOMA Corporation | -29 Million USD | 2231.807% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 974.47% |
| Bionomics Limited | 227 Million USD | -172.334% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 631.659% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 24506.79% |
| uniQure N.V. | -102.95 Million USD | 700.503% |
| Cassava Sciences, Inc. | -121.13 Million USD | 610.355% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 14941.788% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -1409.668% |
| Forte Biosciences, Inc. | -11.96 Million USD | 5268.665% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 20080.092% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -583130.19% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 19163.336% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -6842.437% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 8436.354% |
| Altimmune, Inc. | -134.48 Million USD | 559.691% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -212.132% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 24506.79% |
| Compugen Ltd. | -12.9 Million USD | 4890.949% |
| Peak Bio, Inc. | 10.34 Million USD | -5878.864% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 218553.711% |
| Benitec Biopharma Inc. | -50.58 Million USD | 1322.221% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 692.52% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -3046.979% |
| Zura Bio Limited | -99.8 Million USD | 719.426% |
| PolyPid Ltd. | 6.17 Million USD | -9919.838% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -734.085% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -3046.979% |
| Instil Bio, Inc. | 75.35 Million USD | -720.383% |
| argenx SE | -2.02 Billion USD | 130.472% |
| Immunome, Inc. | -97.02 Million USD | 737.154% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 2848.273% |
| Verona Pharma plc | -220.44 Million USD | 380.446% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 961.72% |
| Shattuck Labs, Inc. | -121.42 Million USD | 609.145% |
| CervoMed Inc. | -7.79 Million USD | 8033.225% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 433.276% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 14237.297% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 569.276% |
| Moolec Science SA | 117.61 Thousand USD | -525529.167% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 27120.551% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -3788.597% |
| AnaptysBio, Inc. | -18.15 Million USD | 3506.005% |
| Design Therapeutics, Inc. | -18.15 Million USD | 3506.193% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 978.396% |
| NeurAxis, Inc. | 145.7 Thousand USD | -424212.973% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -5404.131% |
| Lumos Pharma, Inc. | -28.49 Million USD | 2269.74% |
| Achilles Therapeutics plc | -126.92 Million USD | 587.082% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 961.72% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 94380.268% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 3075.976% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -42298.502% |
| Nutriband Inc. | -251.65 Thousand USD | 245761.357% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 4793.827% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 8409.462% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -81.725% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -2504.693% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 238.159% |
| Palisade Bio, Inc. | -12.06 Million USD | 5224.961% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 540.61% |
| Beam Therapeutics Inc. | -262.72 Million USD | 335.315% |
| Neurogene Inc. | -131.95 Million USD | 568.511% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -2733.81% |
| AEON Biopharma, Inc. | -4.88 Million USD | 12768.525% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 263.902% |
| Sesen Bio, Inc. | -112.55 Million USD | 649.274% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 719.091% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 26432.134% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 1684.134% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 842.326% |
| Athira Pharma, Inc. | -88.99 Million USD | 794.642% |
| Vaccinex, Inc. | -1.28 Million USD | 48098.758% |
| HCW Biologics Inc. | 2.85 Million USD | -21541.376% |
| XOMA Corporation | -29 Million USD | 2231.807% |
| Nektar Therapeutics | 210.24 Million USD | -194.056% |
| Arvinas, Inc. | -313.8 Million USD | 297.012% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -37994.018% |
| Merus N.V. | -192.88 Million USD | 420.516% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -930.631% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 9010.695% |
| Rezolute, Inc. | -68.16 Million USD | 1006.912% |
| Clene Inc. | 3.34 Million USD | -18409.701% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 4788.132% |
| BeyondSpring Inc. | -13.75 Million USD | 4594.54% |
| Synlogic, Inc. | -6.68 Million USD | 9347.928% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -54417.108% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 7411.934% |
| Peak Bio, Inc. | 10.34 Million USD | -5878.864% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 850.09% |
| Krystal Biotech, Inc. | -350.23 Million USD | 276.517% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -398.066% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 465.822% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 19681.749% |
| MannKind Corporation | 143.89 Million USD | -329.624% |
| Ikena Oncology, Inc. | -109.15 Million USD | 666.367% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 8265.685% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 1967.746% |
| Gossamer Bio, Inc. | 180.35 Million USD | -242.782% |
| CohBar, Inc. | -5.93 Million USD | 10524.078% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 2178.204% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -13439.728% |
| Legend Biotech Corporation | -949.39 Million USD | 165.117% |
| Mural Oncology plc | -255.84 Million USD | 341.642% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -1819.056% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 13223.986% |
| Disc Medicine, Inc. | -358.28 Million USD | 272.553% |
| Champions Oncology, Inc. | 4.81 Million USD | -12747.548% |
| REGENXBIO Inc. | 54.76 Million USD | -1028.805% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 230002.532% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 509.355% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 6960.004% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 866.238% |
| Vaxart, Inc. | -8.24 Million USD | 7601.808% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 1332.014% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 586.156% |
| Cellectis S.A. | -43.85 Million USD | 1509.7% |
| Longeveron Inc. | -2.9 Million USD | 21359.422% |
| Repare Therapeutics Inc. | -107.85 Million USD | 673.183% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 36.159% |
| Inozyme Pharma, Inc. | 12 Million USD | -5050.15% |
| Revolution Medicines, Inc. | -608.2 Million USD | 201.647% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 50362.114% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 333.189% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 511.952% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 4051.07% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 83643.784% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 106.464% |
| Denali Therapeutics Inc. | -74.86 Million USD | 925.785% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 5255.432% |
| Veru Inc. | 4.77 Million USD | -12833.64% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 5597.279% |
| Cingulate Inc. | 3.08 Million USD | -19954.738% |
| Passage Bio, Inc. | 4.58 Million USD | -13383.621% |
| Context Therapeutics Inc. | -14.44 Million USD | 4378.418% |
| Exicure, Inc. | 5.84 Million USD | -10469.738% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 368.354% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 1662.355% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -3839.991% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 1151.026% |
| Nuvalent, Inc. | -335.38 Million USD | 284.332% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -35546.047% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 930.031% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 7054.151% |
| OmniAb, Inc. | 9.2 Million USD | -6617.636% |
| Anew Medical, Inc. | 1.43 Million USD | -43058.053% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -3673.857% |
| Lipocine Inc. | -4.75 Million USD | 13102.672% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 662.902% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -3958.985% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1320.363% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -2383.625% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 9298.393% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 1039.165% |
| Ocugen, Inc. | -32.52 Million USD | 2000.999% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 822.435% |
| Q32 Bio Inc. | -37.94 Million USD | 1729.135% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 98543.312% |
| Alumis Inc. Common Stock | -13.52 Million USD | 4669.621% |
| Equillium, Inc. | -22.39 Million USD | 2860.915% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 2517.96% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 1994.837% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 249469.341% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -361.217% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -19231.582% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -188129.85% |
| Dominari Holdings Inc. | 195 Thousand USD | -316937.949% |
| Edesa Biotech, Inc. | -5.26 Million USD | 11837.888% |
| vTv Therapeutics Inc. | -8.91 Million USD | 7033.094% |
| Bio-Techne Corporation | 267.74 Million USD | -130.899% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 3914.079% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 623.502% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 7457.182% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 4986.76% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 352.214% |
| Nkarta, Inc. | 57.29 Million USD | -978.944% |
| BioCardia, Inc. | 212 Thousand USD | -291515.095% |
| Iterum Therapeutics plc | 13.43 Million USD | -4500.566% |